Shockwave therapy eases back pain, but not enough to change what you can do

Chronic low back pain is one of the most common reasons people seek treatment, and clinics increasingly offer extracorporeal shockwave therapy alongside exercise and physiotherapy. Before paying for a course of sessions, patients and clinicians need to know two things: does it actually reduce pain, and does that translate into being able to do more day to day. The two outcomes are not the same, and a treatment can move one without moving the other. This review set out to answer both questions by pooling the randomised evidence.

The authors searched seven databases including PubMed, Embase, Web of Science and the Cochrane Library for randomised trials of shockwave therapy in people with chronic low back pain. Comparators included placebo, usual care, exercise and physiotherapy. From 430 records identified, nine trials met the criteria. They extracted details of participants, interventions, comparators and the dose settings of the shockwave devices, then pooled results for pain intensity and functional disability, distinguishing radial from focused shockwave therapy.

Radial shockwave therapy produced a significant reduction in pain, while the focused version showed benefit in only one trial. Functional disability improved significantly overall, but the size of the improvement did not reach the minimal clinically important difference, the threshold at which patients would typically notice a real change in daily life. Most trials measured outcomes only immediately after the intervention, so nothing can be said about lasting effects. Sensitivity analyses also showed that study quality and disagreement between studies influenced the results.

The findings support shockwave therapy as a possible short-term adjunct to rehabilitation for chronic low back pain rather than a standalone fix, which echoes the authors' own framing that it should complement, not replace, exercise-based rehabilitation and patient education. It also establishes that radial and focused shockwave should not be treated as interchangeable, since they behaved differently here. Open questions remain about which device settings work best, how long any benefit lasts, and whether function can improve in a way patients actually feel. Standardised protocols are still needed.

If a clinic offers shockwave therapy for a persistent bad back, this review gives a reason to expect some short-term pain relief, particularly from the radial version, but not a transformation in what your back lets you do. It is also a reason to ask which type of shockwave is being used, since the two are not equivalent. Anyone weighing up the cost of a course of sessions can reasonably note that the pooled trials only looked at outcomes immediately after treatment.